
A San Francisco-based software company received permission from the U.S. Food and Drug Administration to use Apple Inc. (NASDAQ:AAPL) wearable technology to track Parkinson's symptoms.
Rune Labs' StrivePD software "draws data directly from Apple's Movement Disorder API, which provides a power-efficient approach to measuring and recording tremors and dyskinetic symptoms common in patients with Parkinson's disease," the company explained in a prepared statement.